You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

LEVOCARNITINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Levocarnitine

A generic version of LEVOCARNITINE was approved as levocarnitine by HIKMA on March 29th, 2001.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LEVOCARNITINE?
  • What are the global sales for LEVOCARNITINE?
  • What is Average Wholesale Price for LEVOCARNITINE?
Summary for LEVOCARNITINE
Drug patent expirations by year for LEVOCARNITINE
Drug Prices for LEVOCARNITINE

See drug prices for LEVOCARNITINE

Recent Clinical Trials for LEVOCARNITINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Oncology GroupPhase 3
Children's Hospital of Orange CountyEarly Phase 1
University of California, IrvineEarly Phase 1

See all LEVOCARNITINE clinical trials

Pharmacology for LEVOCARNITINE
Drug ClassCarnitine Analog

US Patents and Regulatory Information for LEVOCARNITINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 075861-001 Jun 22, 2001 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc LEVOCARNITINE levocarnitine SOLUTION;ORAL 212533-001 Nov 10, 2021 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma LEVOCARNITINE levocarnitine SOLUTION;ORAL 077399-001 Oct 25, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novitium Pharma LEVOCARNITINE levocarnitine TABLET;ORAL 216384-001 Dec 9, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.